Ablation of Bscl2/seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy
Mutations affecting the BSCL2 gene cause the most severe form of congenital generalised lipodystrophy (CGL). Affected individuals develop severe metabolic complications including diabetes and hepatic steatosis. Bscl2-deficient mice almost entirely reproduce the CGL phenotype. Adipose tissue-specific...
Saved in:
Main Authors: | George D. Mcilroy (Author), Sharon E. Mitchell (Author), Weiping Han (Author), Mirela Delibegović (Author), Justin J. Rochford (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adipose specific disruption of seipin causes early-onset generalised lipodystrophy and altered fuel utilisation without severe metabolic disease
by: George D. Mcilroy, et al.
Published: (2018) -
Identification of genetic suppressors for a BSCL2 lipodystrophy pathogenic variant in Caenorhabditis elegans
by: Xiaofei Bai, et al.
Published: (2024) -
Berardinelli-Seip congenital lipodystrophy 2/SEIPIN determines brown adipose tissue maintenance and thermogenic programing
by: Hongyi Zhou, et al.
Published: (2020) -
Lipodystrophy and severe metabolic dysfunction in mice with adipose tissue-specific insulin receptor ablation
by: Guifen Qiang, et al.
Published: (2016) -
Seipin oligomers can interact directly with AGPAT2 and lipin 1, physically scaffolding critical regulators of adipogenesis
by: Md. Mesbah Uddin Talukder, et al.
Published: (2015)